And so we are using really the same path of clinical study of [rigor] to applying to the CNS indications Rett Syndrome, Parkinson's with dementia and Alzheimer's disease, which so far has been only applied to oncology and that's also something which Anavex believes is at the forefront in that regard.”
Excellent, this is a perfect example of what I have been looking for. Also, at some point someone has to point out that NO ONE HAS EVER (fill in the blank). Now that gets support from even the most cynical.
Anavex is leading down the same path that has shown success in onocology....exactly what we want investors to be aware of. No risk, just facts.
Market Data 
Markets 
AI
